femoral bifurcation

Clinical Update

The STAND Trial: How the MicroStent Attempts to Break Through Barriers in Below-the-Knee CLI

05/21/2020

Omosalewa Adenikinju, MD; Michael Patel, MD; Adam Zybulewski, MD; Brandon Olivieri, MD; Robert E. Beasley, MD

Mount Sinai Medical Center, Miami Beach, Florida

Omosalewa Adenikinju, MD; Michael Pat...

To understand the intent behind the STAND (Clinical Evaluation of the MicroSTent PeripherAl Vascular SteNt in Subjects with Arterial Disease Below the Knee) trial, one must comprehend the barriers of clinical success in BTK revascularization.

To understand the intent behind...

05/21/2020

Vascular Disease Management

Original Research

Treatment of Common Femoral Artery Lesions Involving the Superficial and Profunda Femoral Artery Bifurcation

05/15/2020

Alberto Cereda, MD¹; Paolo Cioffi, MD¹; Riccardo Iorio, MD¹; Attilio Cotroneo, MD²; Giuseppe Celano, MD¹; Sante Bongo, MD¹; Gaetano Chiricolo, MD³; Giuseppe Sangiorgi, MD³

¹Department of Cardiology and ²Department of Vascular Surgery, Clinica San Gaudenzio, Novara, Italy; ³Department of Systemic Medicine, Institute of Cardiology, University of Tor Vergata, Rome, Italy

Alberto Cereda, MD1; Paolo Cioffi, MD...

The authors repot on 2 cases at high risk for surgical CFE treated respectively with directional atherectomy and intravascular lithotripsy, with good clinical success both in short- and long-term follow-up.

The authors repot on 2 cases at...

05/15/2020

Vascular Disease Management